Bioactivity | Cystathionine-γ-lyase-IN-1 is a selective cystathionine γ-lyase (CSE) enzyme inhibitor with an IC50 of 6.3 μM[1]. | ||||||||||||
Target | IC50: 6.3 μM (CSE) | ||||||||||||
Invitro | Cystathionine-γ-lyase-IN-1 (compound 2a) completely abrogates L-cysteine-induced vasorelaxation at a concentration of 100 μM[1].Cystathionine-γ-lyase-IN-1 (100 μM; 30 minutes) significantly inhibits the increased H2S production stimulated by L-Cys in mouse aorta homogenates[1]. | ||||||||||||
Name | Cystathionine-γ-lyase-IN-1 | ||||||||||||
CAS | 2165706-30-7 | ||||||||||||
Formula | C7H8N2O2S | ||||||||||||
Molar Mass | 184.22 | ||||||||||||
Appearance | Solid | ||||||||||||
Transport | Room temperature in continental US; may vary elsewhere. | ||||||||||||
Storage |
|
||||||||||||
Reference | [1]. Angela Corvino, et al. Fragment-based de novo design of a cystathionine γ-lyase selective inhibitor blocking hydrogen sulfide production. Sci Rep. 2016 Oct 6;6:34398. |